Skip to content
MedsAcross

Brand family

Cuvitru

Human immunoglobulin g · Takeda Pharmaceuticals
United States
Presentations
5
Markets
1

Cuvitru is a brand of Human immunoglobulin g marketed by Takeda Pharmaceuticals, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Human immunoglobulin g
Brand owner
Takeda Pharmaceuticals
Registered in
United States
Strengths and forms
1000 mg/5 mL injection, 10000 mg/50 mL injection, 2000 mg/10 mL injection, 4000 mg/20 mL injection, 8000 mg/40 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Cuvitru 1000 mg/5 mL injectionSubcutaneous Cold chainTakeda PharmaceuticalsUS FDAAvailable on request
Cuvitru 10000 mg/50 mL injectionSubcutaneous Cold chainTakeda PharmaceuticalsUS FDAAvailable on request
Cuvitru 2000 mg/10 mL injectionSubcutaneous Cold chainTakeda PharmaceuticalsUS FDAAvailable on request
Cuvitru 4000 mg/20 mL injectionSubcutaneous Cold chainTakeda PharmaceuticalsUS FDAAvailable on request
Cuvitru 8000 mg/40 mL injectionSubcutaneous Cold chainTakeda PharmaceuticalsUS FDAAvailable on request

Equivalent brands

Other brands of Human immunoglobulin g.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Cuvitru

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.